SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 166 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $530,604 | -16.7% | 36,543 | +20.0% | 0.00% | – |
| Q2 2023 | $637,276 | -85.6% | 30,448 | -85.5% | 0.00% | -100.0% |
| Q1 2023 | $4,438,431 | +765.6% | 210,153 | +943.1% | 0.00% | – |
| Q4 2022 | $512,742 | -72.1% | 20,147 | -73.6% | 0.00% | -100.0% |
| Q3 2022 | $1,836,000 | +323.0% | 76,391 | +239.0% | 0.00% | – |
| Q2 2022 | $434,000 | +40.9% | 22,535 | +26.9% | 0.00% | – |
| Q1 2022 | $308,000 | -20.2% | 17,756 | +0.8% | 0.00% | – |
| Q4 2021 | $386,000 | +0.8% | 17,608 | -11.9% | 0.00% | – |
| Q3 2021 | $383,000 | +25.6% | 19,993 | +12.8% | 0.00% | – |
| Q2 2021 | $305,000 | +41.2% | 17,717 | +83.6% | 0.00% | – |
| Q1 2021 | $216,000 | -96.9% | 9,648 | -96.9% | 0.00% | -100.0% |
| Q4 2020 | $6,949,000 | +619.4% | 312,463 | +377.5% | 0.00% | – |
| Q3 2020 | $966,000 | +46.4% | 65,438 | +8.8% | 0.00% | – |
| Q1 2020 | $660,000 | – | 60,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 8,076 | $174,522 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 46 | $994 | 0.00% |